ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1279

Pre-Operative Musculoskeletal Comorbidities Limit Improvement in Functional Outcomes and Hip Pain in Total Hip Arthroplasty Patients

Scott Pascal1, David Ayers2, Wenjun Li2, Leslie Harrold3, Jeroan Allison4 and Patricia D. Franklin2, 1University of Massachusetts Medical School, Worcester, MA, 2Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 3Department of Orthopedics and Medicine, University of Massachusetts Medical School, Worcester, MA, 4Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Comorbidity, Musculoskeletal, outcomes and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Epidemiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Pre-Operative Musculoskeletal Comorbidities Limit Improvement In Functional Outcomes And Hip Pain In Total Hip Arthroplasty Patients

Background/Purpose:   Identifying clinical factors predictive of total hip arthroplasty (THA) outcomes is valuable for clinicians and patients to make a data-driven surgical decision. While factors such as age, weight, and medical comorbidities have been shown to affect post-operative pain and/or functional gains following THA, musculoskeletal comorbidities have not been investigated. We evaluated whether lumbar pain and pain in the knees and non-operative hip joints predict poorer 6 month pain relief and functional gain.

Methods:   Data were collected from 2,848 patients enrolled in FORCE-TJR, a national prospective cohort of patients who underwent a primary unilateral total hip replacement due to osteoarthritis. Data including patient demographics, medical comorbidities, emotional health (SF/MCS), low back pain (Oswestry), pain in both hips and knees (HOOS/KOOS pain score), and pre-operative and post-operative function (SF/PCS) were collected pre-operatively and six months post-operatively. Post-THA pain relief and functional gain were analyzed using descriptive statistics as well as linear mixed  regression models, in relation to musculoskeletal comorbid conditions and traditional patient and clinical factors.       

Results:   This cohort was 59% female, with a mean age of 65.4 years and mean BMI of 28.9 (kg/m^2). Out of the 2,848 patients, 992 (34.8%) reported moderate to severe low back pain pre-operatively. In addition, 264 (9.3%) reported moderate to severe pain in at least two non-operative hip or knee joints. After adjusting for gender, age, BMI, emotional health and medical co-morbidities, moderate to severe pre-THA back pain and pain in one or more non-operative hip or knees was significantly correlated (p<0.001) with a smaller improvement in hip pain and function after THA. Additionally, the greater the number of nonsurgical hip and knee joints with pain pre-operatively, the stronger the negative effect on pre-to-6 month post-THA gain in pain and function outcomes.

Conclusion:   The presence of low back pain and pain in non-operative hip and knee joints has a significant negative impact on post-THA pain relief and functional outcome. In addition to traditionally reported clinical factors (i.e. age, weight and medical co-morbidities) the burden of musculoskeletal co-morbidity is an important consideration in predicting post-THA gains. 

Table 1. Predictors of pre-to-6 month post-THA change in HOOS ADL/Function Score

Coefficient

Baseline Characteristics

Age

-0.136***

BMI

-0.109*

Female

0.326

pre SF36 MCS

0.190***

Baseline Hip Function

pre HOOS ADL

-0.886***

pre HOOS Pain

Basline Medical Co-Morbidities

pre MCCOM =1

-1.068

pre MCCOM =2

-3.219**

Pre MCCOM=>3

-4.453**

Baseline Low Back Pain

Pre OSW LB Pain = Mild

-1.207

Pre OSW LB Pain = Moderate

-2.709***

Pre OSW LB Pain = Severe

-3.737***

Other hip or knee joints with pain

Pre Pain HK Joint = 1

-2.571***

Pre Pain HK Joint = 2

-5.866***

Pre Pain HK Joint = 3

-7.422***

Constant

86.19***

*p<0.05, **p<0.01, ***p<0.001


Disclosure:

S. Pascal,
None;

D. Ayers,
None;

W. Li,
None;

L. Harrold,
None;

J. Allison,
None;

P. D. Franklin,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pre-operative-musculoskeletal-comorbidities-limit-improvement-in-functional-outcomes-and-hip-pain-in-total-hip-arthroplasty-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology